- Home
- OTLK vs SUP Comparison
OTLK vs SUP Comparison
Compare OTLK & SUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLK
- SUP
- Stock Information
- Founded
- OTLK 2010
- SUP 1957
- Country
- OTLK United States
- SUP United States
- Employees
- OTLK N/A
- SUP N/A
- Industry
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- SUP Auto Parts:O.E.M.
- Sector
- OTLK Health Care
- SUP Consumer Discretionary
- Exchange
- OTLK Nasdaq
- SUP Nasdaq
- Market Cap
- OTLK 64.6M
- SUP 59.2M
- IPO Year
- OTLK 2016
- SUP N/A
- Fundamental
- Price
- OTLK $1.83
- SUP $1.90
- Analyst Decision
- OTLK Strong Buy
- SUP Buy
- Analyst Count
- OTLK 5
- SUP 1
- Target Price
- OTLK $21.00
- SUP $11.00
- AVG Volume (30 Days)
- OTLK 892.5K
- SUP 82.9K
- Earning Date
- OTLK 02-12-2025
- SUP 03-06-2025
- Dividend Yield
- OTLK N/A
- SUP N/A
- EPS Growth
- OTLK N/A
- SUP N/A
- EPS
- OTLK N/A
- SUP N/A
- Revenue
- OTLK N/A
- SUP $1,265,637,000.00
- Revenue This Year
- OTLK N/A
- SUP N/A
- Revenue Next Year
- OTLK $396.84
- SUP $9.29
- P/E Ratio
- OTLK N/A
- SUP N/A
- Revenue Growth
- OTLK N/A
- SUP N/A
- 52 Week Low
- OTLK $0.87
- SUP $1.70
- 52 Week High
- OTLK $12.85
- SUP $4.57
- Technical
- Relative Strength Index (RSI)
- OTLK 39.18
- SUP 30.22
- Support Level
- OTLK $1.79
- SUP $2.10
- Resistance Level
- OTLK $2.26
- SUP $2.13
- Average True Range (ATR)
- OTLK 0.18
- SUP 0.15
- MACD
- OTLK 0.00
- SUP -0.01
- Stochastic Oscillator
- OTLK 6.09
- SUP 13.56
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About SUP Superior Industries International Inc. (DE)
Superior Industries International Inc is engaged in the design and manufacture of aluminum wheels for sale to OEMs in North America and Europe and to the aftermarket in Europe. The company's OEM aluminum wheels are primarily sold for factory installation on vehicle models manufactured by BMW (including Mini), Daimler (Mercedes-Benz, AMG, Smart), Ford, GM, Honda, Jaguar-Land Rover, Lucid Motors, Mazda, Nissan, PSA, Renault, Stellantis, Subaru, Suzuki, Toyota, VW Group (Volkswagen, Audi, SEAT, Skoda, Porsche, Bentley) and Volvo. It sells aluminum wheels to the European aftermarket under the brands ATS, RIAL, ALUTEC, and ANZIO.